Pair Name | Parthenolide, Epirubicin | ||
Phytochemical Name | Parthenolide (PubChem CID: 7251185 ) | ||
Anticancer drug Name | Epirubicin (PubChem CID: 41867 ) | ||
Structure of Phytochemical |
Download
2D
MOL
3D
MOL
|
||
Structure of Anticancer Drug |
Download
2D
MOL
3D
MOL
|
Drug Name | Epirubicin |
Adverse Reactions | Nausea, vomiting, diarrhoea, loss of appetite, inhibition of bone marrow haematopoiesis. This was inferred cold nature anticancer drug. |
Recommendations | Hot: Pinellia ternata |
Reference | ADReCS-Target: target profiles for aiding drug safety research and application. Nucleic Acids Res. 2018 Jan 4;46(D1):D911-D917. doi: 10.1093/nar/gkx899. ref_link |
Pair Name | Parthenolide, Epirubicin | |||
Disease Info | [ICD-11: 2C60] | Breast cancer | Investigative | |
Biological Phenomena | Induction-->Apoptosis | |||
Gene Regulation | Up-regulation | Expression | BAX | hsa581 |
Down-regulation | Expression | BCL2 | hsa596 | |
Up-regulation | Expression | CASP3 | hsa836 | |
In Vitro Model | MDA-MB-468 | Breast adenocarcinoma | Homo sapiens (Human) | CVCL_0419 |
Result | According to lack of cytotoxicity of Parthenolide on normal cells that lead to reduction of drug side effects, it could be suggested as an adjuvant therapy with Epirubicin after complementary research on animal model and clinical trial. |
No. | Title | Href |
---|---|---|
1 | Anticancer and apoptotic activities of parthenolide in combination with epirubicin in mda-mb-468 breast cancer cells. Mol Biol Rep. 2020 Aug;47(8):5807-5815. doi: 10.1007/s11033-020-05649-3. | Click |